Can-Fite BioPharma
(NYSEMKT) CANF
Can-Fite BioPharma Financials at a Glance
Market Cap
$6.45M
Revenue (TTM)
$560.00K
Net Income (TTM)
$8.80M
EPS (TTM)
$-12.45
P/E Ratio
-0.24
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Price
$3.01
Volume
2,072
Open
$2.97
Price
$3.01
Volume
2,072
Open
$2.97
Previous Close
$3.01
Daily Range
$2.97 - $3.10
52-Week Range
$2.95 - $36.40
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Price
$3.01
Volume
2,072
Open
$2.97
Previous Close
$3.01
Daily Range
$2.97 - $3.10
52-Week Range
$2.95 - $36.40
CANF News
CANF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Can-Fite BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Motti Farbstein
Website
www.canfite.comHeadquarters
Petah Tikva, 4951778, IL
CANF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-18%
Net Income Margin
-18%
Return on Equity
0%
Return on Capital
-1%
Return on Assets
-89%
Earnings Yield
-4.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.45M
Shares Outstanding
2.14M
Volume
2.07K
Short Interest
0.00%
Avg. Volume
722.61K
Financials (TTM)
Gross Profit
$384.02K
Operating Income
$10.03M
EBITDA
$10.00M
Operating Cash Flow
$9.02M
Capital Expenditure
$2.02K
Free Cash Flow
$9.02M
Cash & ST Invst.
$8.54M
Total Debt
$71.00K
Can-Fite BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$101.00K
-36.1%
Gross Profit
$101.00K
-36.1%
Gross Margin
100.00%
N/A
Market Cap
$6.45M
N/A
Market Cap/Employee
$1.29M
N/A
Employees
5
N/A
Net Income
$2.44M
-23.2%
EBITDA
$2.44M
-19.1%
Quarterly Fundamentals
Net Cash
$6.37M
+36.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$33.00K
+57.1%
Short Term Debt
$57.00K
+58.3%
Return on Assets
-88.57%
N/A
Return on Invested Capital
-1.23%
N/A
Free Cash Flow
$2.38M
-17.6%
Operating Cash Flow
$2.38M
-17.7%